Published in Am J Psychiatry on June 01, 2003
Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect (2006) 3.56
Adolescents' motivations to abuse prescription medications. Pediatrics (2006) 3.36
Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health (2006) 2.83
Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health (2006) 2.77
Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs (2006) 2.56
Stimulant medication use in children: a 12-year perspective. Am J Psychiatry (2012) 2.27
Trends and college-level characteristics associated with the non-medical use of prescription drugs among US college students from 1993 to 2001. Addiction (2007) 1.97
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry (2010) 1.84
Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry (2010) 1.55
Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Arch Pediatr Adolesc Med (2008) 1.49
Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv (2007) 1.41
A review of the economic burden of ADHD. Cost Eff Resour Alloc (2005) 1.39
Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder? Clin Child Fam Psychol Rev (2012) 1.31
Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey. Public Health Rep (2005) 1.28
Nicotine-induced plasticity during development: modulation of the cholinergic system and long-term consequences for circuits involved in attention and sensory processing. Neuropharmacology (2008) 1.26
Characteristics associated with the diversion of controlled medications among adolescents. Drug Alcohol Depend (2011) 1.26
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr (2012) 1.15
Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States. Biomed Res Int (2013) 1.04
Ten-year increase in service use in the Dutch population. Eur Child Adolesc Psychiatry (2008) 1.01
Longitudinal trends in diagnosis at child and adolescent mental health centres in Madrid, Spain. Eur Child Adolesc Psychiatry (2013) 1.00
One size does not fit all: taking diversity, culture and context seriously. Adm Policy Ment Health (2010) 0.99
Rx for a party: a qualitative analysis of recreational pharmaceutical use in a collegiate setting. J Am Coll Health (2009) 0.96
Stigma in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2012) 0.96
The dopamine dilemma: using stimulants and antipsychotics concurrently. Psychiatry (Edgmont) (2010) 0.95
Long-term consequences of childhood ADHD on criminal activities. J Ment Health Policy Econ (2009) 0.95
Racial/ethnic disparity trends in children's mental health care access and expenditures from 2002 to 2007. Health Serv Res (2012) 0.94
Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits. Biol Psychiatry (2010) 0.94
Prevalence of methylphenidate use among Canadian children following parental divorce. CMAJ (2007) 0.94
Disparities in the reporting and treatment of health conditions in children: an analysis of the Medical Expenditure Panel Survey. Health Serv Res (2006) 0.94
Parental preferences and goals regarding ADHD treatment. Pediatrics (2013) 0.93
Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students. J Pharm Pract (2011) 0.91
Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008. Psychiatr Serv (2013) 0.90
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder. PLoS One (2012) 0.88
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv (2013) 0.86
Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence (2011) 0.86
Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder. Acad Pediatr (2012) 0.84
Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder. Expert Rev Neurother (2011) 0.83
ADHD, temperament, and parental style as predictors of the child's attachment patterns. Child Psychiatry Hum Dev (2006) 0.82
Associations of prenatal maternal smoking with offspring hyperactivity: causal or confounded? Psychol Med (2013) 0.81
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. Pharmacoeconomics (2012) 0.80
Using freelisting to understand shared decision making in ADHD: parents' and pediatricians' perspectives. Patient Educ Couns (2010) 0.80
Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices. J Atten Disord (2012) 0.79
A systematic review of global publication trends regarding long-term outcomes of ADHD. Front Psychiatry (2012) 0.79
Ethnic differences in ADHD and the mad/bad debate. Am J Psychiatry (2004) 0.79
Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice. Eur J Pharmacol (2012) 0.79
Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder. Neuropsychiatr Dis Treat (2007) 0.77
Use of Mental Health Services by Children Ages Six to 11 With Emotional or Behavioral Difficulties. Psychiatr Serv (2015) 0.77
Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder. Health Serv Res (2009) 0.76
Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder. J Anxiety Disord (2014) 0.76
Acculturation differences in communicating information about child mental health between Latino parents and primary care providers. J Immigr Minor Health (2014) 0.75
Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth. Pediatrics (2017) 0.75
Adverse effects of psychotropic medications in children: predictive factors. J Can Acad Child Adolesc Psychiatry (2014) 0.75
A cross-cultural comparison between samples of Brazilian and German children with ADHD/HD using the Child Behavior Checklist. Eur Arch Psychiatry Clin Neurosci (2007) 0.75
Patterns of concurrent substance use among adolescent nonmedical ADHD stimulant users. Addict Behav (2015) 0.75
The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation? Innov Clin Neurosci (2011) 0.75
Use of neuroenhancement drugs: prevalence, frequency and use expectations in Switzerland. Int J Environ Res Public Health (2014) 0.75
Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample. Soc Sci Res (2016) 0.75
Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review. J Atten Disord (2015) 0.75
Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States. J Child Adolesc Psychopharmacol (2017) 0.75
National trends in the outpatient treatment of depression. JAMA (2002) 7.09
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
The most expensive medical conditions in America. Health Aff (Millwood) (2002) 5.50
National patterns in antidepressant medication treatment. Arch Gen Psychiatry (2009) 4.82
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Trends in mental health care among children and adolescents. N Engl J Med (2015) 3.54
Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry (2006) 3.50
Trends in care by nonphysician clinicians in the United States. N Engl J Med (2003) 3.24
Retractions in the research literature: misconduct or mistakes? Med J Aust (2006) 3.17
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care (2011) 2.81
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
National survey of psychotherapy training in psychiatry, psychology, and social work. Arch Gen Psychiatry (2006) 2.53
Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry (2012) 2.50
Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Serv (2007) 2.41
Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry (2003) 2.40
Religiosity and major depression in adults at high risk: a ten-year prospective study. Am J Psychiatry (2011) 2.35
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics (2008) 2.32
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Interventions for adolescent depression in primary care. Pediatrics (2006) 2.28
National trends in outpatient psychotherapy. Am J Psychiatry (2010) 2.24
Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry (2004) 2.24
National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry (2002) 2.22
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry (2006) 1.93
Improving recognition of adolescent depression in primary care. Arch Pediatr Adolesc Med (2006) 1.92
Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther (2006) 1.92
Training and consultation to promote implementation of an empirically supported treatment: a randomized trial. Psychiatr Serv (2012) 1.87
Parental depression, child mental health problems, and health care utilization. Med Care (2003) 1.86
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry (2009) 1.82
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics (2007) 1.82
National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry (2005) 1.80
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. Health Aff (Millwood) (2013) 1.76
Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry (2006) 1.74
Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry (2008) 1.73
Screening for bipolar disorder in a primary care practice. JAMA (2005) 1.72
Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry (2010) 1.67
Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatr Serv (2007) 1.67
Comparison of public attributions, attitudes, and stigma in regard to depression among children and adults. Psychiatr Serv (2007) 1.66
The organizational social context of mental health services and clinician attitudes toward evidence-based practice: a United States national study. Implement Sci (2012) 1.65
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry (2003) 1.63
National trends in the use of outpatient psychotherapy. Am J Psychiatry (2002) 1.59
Psychiatric opinion and antipsychotic selection in the management of schizophrenia. Psychiatr Serv (2008) 1.56
Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children. J Am Acad Child Adolesc Psychiatry (2008) 1.53
Evidence-based practice for acute low back pain in primary care: patient outcomes and cost of care. Pain (2006) 1.52
Growth and decentralization of the medical literature: implications for evidence-based medicine. J Med Libr Assoc (2005) 1.50
Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics (2007) 1.48
Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry (2002) 1.48
Tracking publication outcomes of National Institutes of Health grants. Am J Med (2005) 1.48
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics (2007) 1.48
Emergency treatment of young people following deliberate self-harm. Arch Gen Psychiatry (2005) 1.47
Social anxiety disorder in primary care. Gen Hosp Psychiatry (2005) 1.46
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol (2003) 1.46
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol (2002) 1.45
Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med (2005) 1.42
Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv (2007) 1.41
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41
Characterizing Primary Care Visit Activities at Veterans Health Administration Clinics. J Healthc Manag (2015) 1.40
Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry (2005) 1.39
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry (2003) 1.39
The role of treatment fidelity on outcomes during a randomized field trial of an autism intervention. Autism (2013) 1.38
Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000. Arch Gen Psychiatry (2007) 1.37
Medical services for clients in community mental health centers: results from a national survey. Psychiatr Serv (2008) 1.37
Disseminating child & adolescent mental health treatment methods: an international feasibility study. Rev Bras Psiquiatr (2006) 1.37
Training of evidence-based assessment and intervention approaches in cross-cultural contexts: challenges and solutions. Rev Bras Psiquiatr (2006) 1.36
Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34
Development of adaptable and flexible treatment manuals for externalizing and internalizing disorders in children and adolescents. Rev Bras Psiquiatr (2006) 1.32
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31
Posttraumatic stress disorder in primary care one year after the 9/11 attacks. Gen Hosp Psychiatry (2006) 1.28
Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry (2003) 1.28
National trends in nonoperative care for nonspecific back pain. Spine J (2004) 1.24
Psychotic symptoms in an urban general medicine practice. Am J Psychiatry (2002) 1.24
Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23
The Application of Behavior Change Theory to Family-Based Services: Improving Parent Empowerment in Children's Mental Health. J Child Fam Stud (2010) 1.23
Datapoints: trends by race and gender in suicide attempts among U.S. adolescents, 1991-2001. Psychiatr Serv (2003) 1.22
Implications of childhood autism for parental employment and earnings. Pediatrics (2012) 1.22
Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatr Serv (2006) 1.21
Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry (2004) 1.20
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18
The mental health consequences of disaster-related loss: findings from primary care one year after the 9/11 terrorist attacks. Psychiatry (2008) 1.17
Mental comorbidity and quality of diabetes care under Medicaid: a 50-state analysis. Med Care (2012) 1.16
AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations. J Am Acad Child Adolesc Psychiatry (2004) 1.15
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15
Age of diagnosis among Medicaid-enrolled children with autism, 2001-2004. Psychiatr Serv (2010) 1.14
Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. Psychiatr Serv (2007) 1.13
Treatment of obsessive-compulsive disorder by U.S. psychiatrists. J Clin Psychiatry (2006) 1.13
Depressed mothers coming to primary care: maternal reports of problems with their children. J Affect Disord (2004) 1.12
Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry (2006) 1.12
Mental health assessments in juvenile justice: report on the consensus conference. J Am Acad Child Adolesc Psychiatry (2003) 1.11